MARKET

COO

COO

Cooper
NYSE

Real-time Quotes | Nasdaq Last Sale

339.84
-1.21
-0.35%
Closed 16:03 05/25 EDT
OPEN
338.87
PREV CLOSE
341.05
HIGH
342.91
LOW
336.97
VOLUME
349.32K
TURNOVER
--
52 WEEK HIGH
463.59
52 WEEK LOW
309.43
MARKET CAP
16.75B
P/E (TTM)
18.04
1D
5D
1M
3M
1Y
5Y
KeyBanc Adjusts Price Target on Cooper Cos. to $414 From $459, Reiterates Overweight Rating
MT Newswires · 1d ago
Wells Fargo Adjusts Cooper Cos.' Price Target to $380 from $495, Keeps Overweight Rating
MT Newswires · 2d ago
CooperCompanies Releases 2021 Environmental, Social, and Governance Highlights Report; Signs on to United Nations Global Compact
CooperCompanies has published its 2021 Environmental, Social, and Governance (ESG) Highlights Report, sharing the Company’s progress on ESG items most important to its businesses and stakeholders, ...
News Direct · 6d ago
Here's Why You Should Retain Cooper Companies (COO) Stock Now
Cooper Companies (COO) continues to benefit from strength in its business segments.
Zacks · 05/18 15:01
The Cooper Companies gains as Citi upgrades citing a strong eye care market
Citi analysts upgraded The Cooper Companies (NYSE:COO) to Buy from Neutral on Tuesday, noting a healthy eye care market even as the San Ramon, California-based contact lens maker battles forex
Seekingalpha · 05/17 17:35
Cooper Companies' Shares Rise After Citigroup Upgrade
MT Newswires · 05/17 14:19
Citigroup Upgrades Cooper Cos. to Buy From Neutral
MT Newswires · 05/17 07:03
Alpine Immune Sciences, Inc. (ALPN) Reports Q1 Loss, Tops Revenue Estimates
Alpine Immune Sciences, Inc. (ALPN) delivered earnings and revenue surprises of -47.06% and 2.07%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 05/12 21:55
More
No Data
Learn about the latest financial forecast of COO. Analyze the recent business situations of Cooper through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 16 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

31.25%Strong Buy
25.00%Buy
37.50%Hold
6.25%Under-perform
0.00%Sell
Analyst Price Target
The average COO stock price target is 471.00 with a high estimate of 560.00 and a low estimate of 385.00.
High560.00
Average471.00
Low385.00
Current 339.84
EPS
Actual
Estimate
0.871.732.603.46
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 823
Institutional Holdings: 56.83M
% Owned: 115.27%
Shares Outstanding: 49.30M
TypeInstitutionsShares
Increased
207
2.72M
New
68
453.73K
Decreased
190
2.48M
Sold Out
60
192.74K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+0.15%
Healthcare Equipment & Supplies
-0.41%
Key Executives
Non-Executive Chairman/Independent Director
Robert Weiss
President/Chief Executive Officer/Director
Albert White
Chief Financial Officer/Executive Vice President/Treasurer
Brian Andrews
Corporate Executive
Holly Sheffield
Corporate Executive
Gerard Warner
Chief Operating Officer/Executive Vice President
Daniel McBride
Senior Vice President - Finance/Chief Accounting Officer
Agostino Ricupati
Vice President/General Counsel/Secretary
Mark Drury
Lead Director/Independent Director
William Kozy
Independent Director
Colleen Jay
Independent Director
Jody Lindell
Independent Director
Teresa Madden
Independent Director
Gary Petersmeyer
Independent Director
Maria Rivas
No Data
No Data
About COO
The Cooper Companies, Inc. is a global medical device company. The Company operates through two segments: CooperVision and CooperSurgical. The CooperVision segment is engaged in developing, manufacturing, and marketing a range of products for contact lens wearers, featuring advanced materials and optics. CooperVision designs its products to solve vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues, with a collection of spherical, toric and multifocal contact lenses. The CooperSurgical segment is focused on advancing the health of women, babies, and families through a diversified portfolio of products and services including medical devices, fertility, diagnostics and contraception. CooperSurgical's products are used in medical office and surgical procedures, primarily by obstetricians/gynecologists (OB/GYN); and fertility products/equipment and genetic testing services used primarily in fertility clinics and laboratories.

Webull offers kinds of Cooper Companies Inc stock information, including NYSE:COO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, COO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading COO stock methods without spending real money on the virtual paper trading platform.